Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
-
Immusoft Announces Presentation of World's First Patient Treated with an Engineered B Cell Therapy at Workshop Co-Hosted by FDA and ARM
-
Loblaw Companies Limited Announces the Timing of the First Quarter 2026 Earnings Release and Annual Meeting of Shareholders
-
Software from tech startup Leto helps caseworkers connect clients with community resources
-
BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
-
Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
-
TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
-
FactSet Announces Chief Financial Officer Transition
-
Immusoft Announces Presentation of World's First Patient Treated with an Engineered B Cell Therapy at Workshop Co-Hosted by FDA and ARM
-
Veteran Private Equity Investor Seth Harward Joins Siris as Managing Director – Business Development
-
BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026
-
Anfield Energy Submits Permit Amendment for JD-8 Mine Restart
-
CEO Address to Shareholders
-
Xali Gold Adds Permitting Expert to Development and Operations Team at Pico Machay Gold Project in Peru
-
Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced Consumer
-
Exol™ Launches U.S. Physical AI Facilities and Groundbreaking Fulfillment-as-a-Service Model to Expand Access to Enterprise-Grade Automation
-
Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Monday, April 20, 2026
-
Incyclix Bio Raises Additional $5 Million in Series B Financing to Advance Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
-
Capstreet-backed Analytic Stress Appoints Paul Stouffer as CEO
-
iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia
-
Anthony’s and Women’s Golf Association at PGA National Raise Scholarship Funds for Future Women Leaders
-
Barrick Welcomes Ontario Court of Appeal’s Dismissal of Appeal Concerning North Mara Gold Mine
-
MEDvidi Launches AI Prescribing Assistant to Tackle America’s Mental Health Access Crisis
-
Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
-
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
-
CHUCK E. CHEESE LAUNCHES 2026 SUMMER FUN PASS WITH FIVE MONTHS OF UNLIMITED VISITS AND MORE PERKS
-
OR Royalties Announces Preliminary Q1 2026 GEO Deliveries and C$17.7 Million of Share Repurchases Under the Normal Course Issuer Bid
-
Middle East disruption could cut global oil demand 20% and gas 10% by 2050 as energy security drives shift to independence
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Endeavour Silver Produces 1,875,375 Oz Silver and 11,740 Oz Gold, for a total of 3.3 Million Silver Equivalent Oz in Q1 2026
-
Reliance, Inc. to Announce First Quarter 2026 Results on Wednesday, April 22nd
-
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
-
RentRedi Earns Inc. Ranking for Third Consecutive Year as DIY Landlords Prefer its Platform to Run Their Entire Rental Business
-
Brookfield Asset Management to Host First Quarter 2026 Results Conference Call
-
B2PRIME Group Announces Record 2025 Results with Strong Growth and Zero Debt
-
BOSS Zhipin Continues Share Repurchases, with Total Repurchases Amounting to Nearly RMB721 Million in 2026
-
Parsons Unifies Aviation Units to Enhance Comprehensive Customer Offerings
-
Publishing Industry Under Attack: Global AI Bot Activity Surges by 300%, Akamai Report Finds
-
HSBC Continental Europe: Pre Stabilisation Notice
-
TRX Gold Reports Robust Recovery Rates from Recent Study and Significant Increase in Plant Expansion Scope
-
Real Messenger Announces Receipt of Nasdaq Notification Letter Regarding Stockholders’ Equity Deficiency
-
Notice of the Annual General Meeting of Rapala VMC Corporation
-
Rapala VMC Corporation’s Annual Report 2025 has been released
-
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
-
AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs
-
MEXC Launches Eighth Anniversary Futures Team Trading Competition With 10 Million USDT Prize Pool
-
Newcore Gold Drilling Intersects 1.59 g/t Gold over 15.5 Metres, Including 3.22 g/t Gold over 6.4 Metres, at the Enchi Gold Project, Ghana
-
Lucidworks Launches Model Context Protocol to Reduce AI Agent Integration Timelines by Up to 10x
-
Eagle Bancorp Announces Earnings Call on April 23, 2026
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Anywhere Real Estate Inc. Investors Who Received Compass, Inc. (COMP) Shares in Connection with Compass’s Acquisition of Anywhere in Jan

